Wenling M. Han

No. 38 Xueyuan Road
Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Identifying Negative Biomarkers of CD4 Cytotoxic T Lymphocytes via Granzyme B Exclusion Analysis.

Identifying Negative Biomarkers of CD4 Cytotoxic T Lymphocytes via Granzyme B Exclusion Analysis.

Journal: European journal of immunology

Published: September 20, 2025

Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD-L1 Expression and Acts as a Target to Enhance Anti-PD-1 Efficacy.

Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD-L1 Expression and Acts as a Target to Enhance Anti-PD-1 Efficacy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 29, 2025

DUSP9 is Up-Regulated and Promotes Tumor Progression in Head and Neck Squamous Cell Carcinoma.

DUSP9 is Up-Regulated and Promotes Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Journal: Journal of Cancer

Published: January 16, 2025

CMTM7 inhibits TLR4 signaling pathway via promoting Rab5 activation and alleviates acute liver injury.

CMTM7 inhibits TLR4 signaling pathway via promoting Rab5 activation and alleviates acute liver injury.

Journal: Cellular and molecular life sciences : CMLS

Published: October 30, 2024

CMTM3 Promotes Colitis-associated Carcinogenesis via CLTC Stabilization and Modulation of VE-cadherin.

CMTM3 Promotes Colitis-associated Carcinogenesis via CLTC Stabilization and Modulation of VE-cadherin.

Journal: Cellular and molecular gastroenterology and hepatology

Published: October 02, 2024

The cytokine CSBF inhibits the IL-17A and TNF-α inflammatory pathways via SUSD2-ACT1 in keratinocytes and alleviates IMQ-induced psoriasis.

The cytokine CSBF inhibits the IL-17A and TNF-α inflammatory pathways via SUSD2-ACT1 in keratinocytes and alleviates IMQ-induced psoriasis.

Journal: Cellular & molecular immunology

Published: September 26, 2024

A CMTM6 Nanobody Overcomes EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

A CMTM6 Nanobody Overcomes EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 11, 2024

Analysis of mutually exclusive expression in cancer cells identifies a previously unknown intergenic regulatory paradigm.

Analysis of mutually exclusive expression in cancer cells identifies a previously unknown intergenic regulatory paradigm.

Journal: The FEBS journal

Published: September 02, 2024

Cmtm4 deficiency exacerbates colitis by inducing gut dysbiosis and S100a8/9 expression.

Cmtm4 deficiency exacerbates colitis by inducing gut dysbiosis and S100a8/9 expression.

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: March 26, 2024

Protocol to examine immune subpopulations in murine conjunctiva and lacrimal gland using flow cytometry.

Protocol to examine immune subpopulations in murine conjunctiva and lacrimal gland using flow cytometry.

Journal: STAR protocols

Published: January 10, 2024

Transmembrane Protein CMTM6 Alleviates Ocular Inflammatory Response and Improves Corneal Epithelial Barrier Function in Experimental Dry Eye.

Transmembrane Protein CMTM6 Alleviates Ocular Inflammatory Response and Improves Corneal Epithelial Barrier Function in Experimental Dry Eye.

Journal: Investigative ophthalmology & visual science

Published: January 02, 2024

Identification of rat Vstm1 with conservative anti-inflammatory effect between rat and human homologs.

Identification of rat Vstm1 with conservative anti-inflammatory effect between rat and human homologs.

Journal: Genomics

Published: September 15, 2023

Showing 1-12 of 65

Last Updated: 09/26/2026